Palisade Bio
Price & Volume
Stats
See more52W Range | $1.33-$22.35 |
Market Cap | $4.5M |
Shares Short | 66,278 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$13.26 |
News
See moreYahoo Finance • last year
Palisade Bio Reports Third Quarter 2023 Financial Results and Provides Business Outlook
Yahoo Finance • last year
Palisade Bio to Participate at the Virtual Investor Ask the CEO Conference
Yahoo Finance • last year
Palisade Bio Transforms GI-Focused Pipeline Through Exclusive Worldwide Licensing Agreement with Giiant Pharma, Inc. for Multiple Oral Drug Candidates Targeting Inflammatory Bowel Disease
Yahoo Finance • 2 years ago
Palisade Bio Announces Completion of Enrollment in LB1148 Dose Optimization Study
About
CEO | Mr. J. D. Finley |
CFO | Mr. J. D. Finley |
Address | 7750 El Camino Real, Carlsbad, CA, United States, 92009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
